No Detail Found!

Preoperative In ammation Markers in Predicting Biochemical Recurrence after Robot-assisted Radical Prostatectomy

Author(s)
Mahmut Taha Olcucu Department of Urology, University of Health Sciences, Antalya Training and Research Hospital,Turkey
Kaan Karamik Department of Urology, University of Health Sciences, Antalya Training and Research Hospital,Turkey
Kayhan Yilmaz Department of Urology, University of Health Sciences, Antalya Training and Research Hospital,Turkey
Cagatay Ozsoy Department of Urology, University of Health Sciences, Antalya Training and Research Hospital,Turkey
Yasin Aktas Department of Urology, University of Health Sciences, Antalya Training and Research Hospital,Turkey
Mutlu Ates Department of Urology, University of Health Sciences, Antalya Training and Research Hospital,Turkey
Abstract
Objective: To evaluate the importance of preoperative neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), and neutrophil-to-monocyte ratio (NMR) in prostate cancer patients, who underwent robot-assisted radical prostatectomy (RARP). Study Design: Observational study. Place and Duration of Study: Urology Department, Antalya Training and Research Hospital, Turkey, between March 2015 and September 2019. Methodology: Four hundred and fty-four patients underwent RARP were scanned. Clinical characteristics and pathological features of patients were recorded. Patients were excluded, if they had persistent PSA; a history of any autoimmune or in ammatory disease; anti-in ammatory agents use; blood transfusion within 3 months; oar follow-up time shorter than 3 months. Systemic in ammation markers were calculated and correlated with patients' data and biochemical recurrence (BCR). Biochemical recurrence was de ned as two repetitive measurements of PSA levels e0.2 ng/mL at 3 months after the radical prostatectomy. Mann-Whitney U-test, Fisher s exact test, and Pearson Chi-square test, ROC curve, Kaplan Meier survival analyses, and Cox proportional hazard regression model were used as statistical methods. Results: Four hundred and two patients were eligible. The median age at RP was65.5 (61-69) years and median PSA of the patients was 8.3 (5.76-12.61) ng/ml. Median NLR, LMR, PLR, and NMR were 2 (1.55-2.61), 3.86 (3.14-5), 105.69 (85-134.29), 7.82 (6.25-9.71); and optimal cut-o values were 2.33, 3.75, 106.6, and 8.75, respectively. Low LMR was found as an important predictor of biochemical recurrence (hazard ratio, HR=1.769, 95% con dence intervCaIl=,1.091 - 2.868, p=0.021). A signi cant association was found between lower LMR and decreased BCR -free survival (p <0.001). Conclusion: Pretreatment low LMR might be a simple and inexpensive index, which re ects the host systemic immunity and can predict independently BCR after RARP.
Publication Details
Page(s) 921-927
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 30, Issue: 9, Year: 2020

Request the full text from PASTIC

Keywords
Prostate cancer, Lymphocyte-to-monocyte ratio, Platelet-to-lymphocyte ratio, Neutrophil-to-monocyte ratio, Biochemical recurrence, Neutrophil-to-lymphocyte ratio
0

Citations

0

Downloads

48

Views